JP Morgan Reinstates Neutral on Deciphera Pharmaceuticals, Announces $14 Price Target
JP Morgan Reinstates Neutral on Deciphera Pharmaceuticals, Announces $14 Price Target
摩根大通對Deciphera Pharmicals恢復中立,宣佈目標股價爲14美元
JP Morgan analyst Jessica Fye reinstates Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Neutral and announces $14 price target.
摩根大通分析師傑西卡·費伊恢復Deciphera Pharmicals(納斯達克股票代碼:DCPH)的股價爲中性,並宣佈了14美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。